NCT05198778View on ClinicalTrials.gov

A Safety, PK, PD and Food Effect Study of URC102 in Healthy Adults and Patients With Renal Impairment

PHASE1CompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

November 29, 2021

Primary Completion Date

July 13, 2022

Study Completion Date

July 13, 2022

Conditions

Healthy, Renal Impairment

Interventions

DRUG

URC102

tablet

DRUG

URC102

tablet

Trial Locations (2)

Unknown

Chungbuk National University Hospital, Cheongju-si

Ajou University Hospital, Suwon

Sponsors

Lead Sponsor

JW Pharmaceutical

All Listed Sponsors

lead

JW Pharmaceutical

INDUSTRY

NCT05198778 - A Safety, PK, PD and Food Effect Study of URC102 in Healthy Adults and Patients With Renal Impairment | Biotech Hunter | Biotech Hunter